U.S. Markets open in 7 hrs 48 mins

Gilead Sciences, Inc. (GILD)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
64.50-0.06 (-0.09%)
At close: 4:00PM EDT
People also watch
CELGBIIBAMGNBMYREGN
Interactive chart
Previous Close64.56
Open64.37
Bid64.50 x 400
Ask64.59 x 2000
Day's Range64.31 - 64.75
52 Week Range63.88 - 88.85
Volume3,646,119
Avg. Volume7,827,619
Market Cap84.28B
Beta0.99
PE Ratio (TTM)6.82
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield2.08 (3.22%)
Ex-Dividend Date2017-03-14
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals6 hours ago

    Gilead Sciences CFO named ‘Financial Woman of the Year’

    The Financial Women of San Francisco selected Gilead Sciences Chief Financial Officer Robin Washington as its 2017 Financial Woman of the Year. Washington was also recognized this week as the recipient of the lifetime achievement award at the “2017 Bay Area CFO of the Year Awards,” a program conducted by Larkin Street Youth Services in partnership with the Business Times. In accepting her award this week, it was clear that Washington spent a good portion of her career staying one step ahead of Oracle’s M&A department.

  • Market Realist15 hours ago

    Truvada Could Drive Gilead Sciences’ Revenue Growth

    In 2016, Gilead Sciences’ (GILD) Truvada generated revenues of around $3.1 billion, reflecting ~3% year-over-year growth.

  • Market Realist17 hours ago

    Why Gilead’s HCV Franchise Could See a Decline in 2017

    Gilead Sciences’ (GILD) HCV franchise was the company's highest revenue-generating division back in 2015.